THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) operates under a 'Farm to Pharma' pharmaceutical model, now holding all three key cannabis licences being a Cannabis Research Licence, a Medicinal Cannabis Licence (Cultivation), and a Manufacture Licence through its domestic medicinal cannabis subsidiaries THC Pharma and Canndeo. THC Global has secured a significant cannabis growing capacity over multiple cultivation projects and owns a pharmaceuticals bio-manufacturing facility with attached testing and product development laboratory. THC Global is in prime position to commence medicinal cannabis production to service both domestic patients and the global export market. THC Global is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East. In addition to its core Australian medicinal cannabis assets, THC Global has a significant Canadian presence – both in cannabis and in hydroponics equipment. THC Global's Canadian cannabis operation, Vertical Canna, holds property in Nova Scotia, Canada being developed into a large scale cannabis production site. THC Global's hydroponics equipment division, Crystal Mountain, is a revenue generating manufacturer, wholesaler, and retailer of hydroponic equipment and supplies.
THC Global Group Limited
ASX:THC ISIN:AU000000THC4
News
THC Global Group Limited (THC Global or the Company) (ASX:THC) (FRA:9TH) (OTCMKTS:HDRPF) provides an update on its offer to Eligible Shareholders to apply for up to $15,000 of new Shares at $0.50 under a Share Purchase Plan offer.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update on Crystal Mountain, the Company's hydroponics equipment division based in Canada.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) provides, in accordance with Listing Rule 3.17.1, a copy of the April 2019 Share Purchase Plan Offer Booklet which has been sent to all Eligible Shareholders today.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) provides, in accordance with Listing Rule 3.17.1, a copy of the April 2019 Briefing Note which has been sent to shareholders of the Company today.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) advises that it will offer Shareholders the opportunity to apply for up to $15,000 of new Shares under a Share Purchase Plan offer, which will open on Tuesday, 9 April 2019.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) has completed a significant first step in its Asian Markets Strategy in securing a mutually exclusive partnership with Malaysian agri-tech company Heleogenics Sdn Bhd.
Your directors present their report, together with the financial statements, on the consolidated entity consisting of THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) and the entities it controlled at the end of, or during, the year ended 31 December 2018.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) advises that its wholly owned subsidiary, Vertical Canna, has completed the acquisition of a Canadian company, 10034622 Canada Inc, which holds the property and is in the process of becoming a Licenced Cultivator of cannabis.
The securities of THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) will be placed in trading halt at the request of THC, pending it releasing an announcement.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to provide an update on the Company's activities as it transitions into full-scale domestic operations having secured almost all licencing and permitting required for its vertically integrated, Farm to Pharma business model.
41,664 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 115) (Last 30 Days: 512) (Since Published: 41664)